Japanese Pharmaceuticals & Biotech Most Popular Stocks

Chugai Pharmaceutical

Market Cap: JP¥11.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.7t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥6.7t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥4.3t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Astellas Pharma

Market Cap: JP¥2.9t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.1t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Ono Pharmaceutical

Market Cap: JP¥797.2b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Sumitomo Pharma

Market Cap: JP¥698.8b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Santen Pharmaceutical

Market Cap: JP¥545.2b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥288.9b

Manufactures and sells pharmaceuticals in Japan.

Tsumura

Market Cap: JP¥264.7b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥226.2b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Nippon Shinyaku

Market Cap: JP¥221.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

SanBio

Market Cap: JP¥211.1b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

PeptiDream

Market Cap: JP¥196.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Kissei Pharmaceutical

Market Cap: JP¥174.9b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Towa Pharmaceutical

Market Cap: JP¥143.6b

Manufactures and sale ethical drugs in Japan.

Kaken Pharmaceutical

Market Cap: JP¥139.1b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

GNI Group

Market Cap: JP¥131.3b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Takara Bio

Market Cap: JP¥114.6b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Mochida Pharmaceutical

Market Cap: JP¥110.1b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Nxera Pharma

Market Cap: JP¥88.5b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Zeria Pharmaceutical

Market Cap: JP¥88.2b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥83.6b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥79.9b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥68.3b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥62.1b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Healios K.K

Market Cap: JP¥57.7b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Cuorips

Market Cap: JP¥55.2b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.

Fuji Pharma

Market Cap: JP¥36.8b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Seikagaku

Market Cap: JP¥35.9b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Daito PharmaceuticalLtd

Market Cap: JP¥35.7b

Manufactures and sells pharmaceutical products worldwide.

3-D Matrix

Market Cap: JP¥33.6b

Develops self-assembling peptide technology in Japan and internationally.

Heartseed

Market Cap: JP¥31.8b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.